Literature DB >> 23818711

Risk of diabetes in patients with rheumatoid arthritis: a 12-year retrospective cohort study.

Che-Chun Su1, Ie-Chiau Chen, Fang-Ning Young, Ie-Bin Lian.   

Abstract

OBJECTIVE: The incidence of type 2 diabetes (T2D) in adults with rheumatoid arthritis (RA) was investigated, and the results were compared with non-RA controls to confirm whether RA is a risk factor for diabetes mellitus (DM) in Taiwan.
METHODS: We used a databank of 1 million individuals randomly selected from 23 million Taiwanese citizens covered by the National Health Insurance plan in 2005. All persons older than age 20 years in 1998 and not diagnosed with either RA or T2D before 1998 were included. They were divided into 2 cohorts, 1 with RA and the other without. Those who had T2D before RA were excluded. Each patient in the RA cohort was followed from the RA diagnosis until the end of 2009, or until dropping out of the insurance coverage. RA was ascertained by at least 3 visits using ICD-9 code 714.0, plus at least 2 visits with prescription of antirheumatic drugs in a period of 12 months. T2D was ascertained by at least 3 visits with diabetes codes within 1 year, while hypertension (HTN) and disorders of lipid metabolism (DLM) were determined by at least 3 visits using corresponding ICD codes during the study period. Kaplan-Meier plots, log-rank tests, and Cox regression were used to study the effects of age, sex, glucocorticoid use, HTN, DLM, and RA on T2D risk.
RESULTS: The subjects include 600,695 adults. Of these, 4193 were diagnosed with RA, and among them 799 were diagnosed with T2D. The RA to non-RA risk ratio for T2D was 1.68 (95% CI 1.53-1.84) in men and 1.46 (95% CI 1.39-1.54) in women.
CONCLUSION: RA appears to be associated with an increased risk for T2D in Taiwan.

Entities:  

Keywords:  DIABETES MELLITUS; DYSLIPIDEMIA; HYPERTENSION; RHEUMATOID ARTHRITIS; RISK; TYPE 2 DIABETES

Mesh:

Substances:

Year:  2013        PMID: 23818711     DOI: 10.3899/jrheum.121259

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus.

Authors:  Sarah K Chen; Hemin Lee; Yinzhu Jin; Jun Liu; Seoyoung C Kim
Journal:  Rheumatol Adv Pract       Date:  2020-06-22

2.  Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study.

Authors:  Ming-Chi Lu; Shih-Tang Yan; Wen-Yao Yin; Malcolm Koo; Ning-Sheng Lai
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 3.  MAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes.

Authors:  Huai-Chia Chuang; Tse-Hua Tan
Journal:  J Biomed Sci       Date:  2017-01-07       Impact factor: 8.410

4.  Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients.

Authors:  Jeffrey R Curtis; Fenglong Xie; Cynthia S Crowson; Eric H Sasso; Elena Hitraya; Cheryl L Chin; Richard D Bamford; Rotem Ben-Shachar; Alexander Gutin; Darl D Flake; Brent Mabey; Jerry S Lanchbury
Journal:  Arthritis Res Ther       Date:  2020-12-04       Impact factor: 5.156

5.  The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis.

Authors:  Zixing Tian; John Mclaughlin; Arpana Verma; Hector Chinoy; Adrian H Heald
Journal:  Cardiovasc Endocrinol Metab       Date:  2021-02-19

6.  Risk of developing depressive disorders following rheumatoid arthritis: a nationwide population-based study.

Authors:  Shu-Li Wang; Cheng-Ho Chang; Li-Yu Hu; Shih-Jen Tsai; Albert C Yang; Zi-Hong You
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

7.  Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis.

Authors:  Janine S Hähnlein; Reza Nadafi; Tineke A de Jong; Johanna F Semmelink; Ester B M Remmerswaal; Mary Safy; Krijn P van Lienden; Mario Maas; Danielle M Gerlag; Paul P Tak; Reina E Mebius; Heidi Wähämaa; Anca I Catrina; Lisa G M van Baarsen
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.